
Results
268
Most Popular Stocks on the market
268 companies
Samsung BiologicsLtd
Market Cap: ₩73.7t
Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,652,000.00
7D
9.0%
1Y
-0.4%
Celltrion
Market Cap: ₩45.1t
A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.
A068270
₩209,000.00
7D
5.9%
1Y
16.3%
ALTEOGEN
Market Cap: ₩20.1t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩360,000.00
7D
8.4%
1Y
-0.3%
Sam Chun Dang Pharm
Market Cap: ₩18.3t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩774,000.00
7D
20.0%
1Y
300.8%
Samsung Epis Holdings
Market Cap: ₩13.2t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩543,000.00
7D
3.4%
1Y
n/a
ABL Bio
Market Cap: ₩10.2t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩182,400.00
7D
19.3%
1Y
378.7%
Kolon TissueGene
Market Cap: ₩8.4t
Develops cell therapies for orthopedic diseases and other unmet medical needs.
A950160
₩98,800.00
7D
8.5%
1Y
114.5%
SK Biopharmaceuticals
Market Cap: ₩7.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩98,700.00
7D
1.2%
1Y
-6.4%
Yuhan
Market Cap: ₩7.3t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩98,500.00
7D
6.6%
1Y
-17.1%
Peptron
Market Cap: ₩6.7t
Engages in the development of peptide-based medicines.
A087010
₩302,000.00
7D
37.3%
1Y
244.7%
LigaChem Biosciences
Market Cap: ₩6.6t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩179,600.00
7D
10.9%
1Y
74.2%
Hanmi Pharm
Market Cap: ₩6.5t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩487,500.00
7D
2.0%
1Y
100.6%
Caregen
Market Cap: ₩6.4t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩123,200.00
7D
15.7%
1Y
379.4%
Voronoi
Market Cap: ₩5.8t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩329,000.00
7D
19.4%
1Y
137.5%
Aimed Bio
Market Cap: ₩4.2t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩65,100.00
7D
26.9%
1Y
n/a
Mezzion PharmaLtd
Market Cap: ₩3.9t
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩120,300.00
7D
4.0%
1Y
323.6%
OliX Pharmaceuticals
Market Cap: ₩3.8t
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩180,000.00
7D
10.2%
1Y
288.3%
D&D Pharmatech
Market Cap: ₩3.6t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩80,200.00
7D
14.6%
1Y
562.1%
PharmaResearch
Market Cap: ₩3.3t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩317,500.00
7D
10.2%
1Y
-3.2%
SK bioscienceLtd
Market Cap: ₩3.3t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩43,850.00
7D
5.9%
1Y
6.8%
ST PharmLtd
Market Cap: ₩3.3t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩158,900.00
7D
20.8%
1Y
114.4%
Hugel
Market Cap: ₩2.8t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩248,000.00
7D
6.0%
1Y
-25.9%
Hanall Biopharma
Market Cap: ₩2.8t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩57,600.00
7D
17.1%
1Y
66.5%
Celltrion Pharm
Market Cap: ₩2.7t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩61,700.00
7D
6.9%
1Y
18.7%
Orum Therapeutics
Market Cap: ₩2.5t
A biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases.
A475830
₩119,900.00
7D
15.3%
1Y
328.2%
Rznomics
Market Cap: ₩2.4t
Develops RNA based gene therapies for cancers and intractable diseases.
A476830
₩166,800.00
7D
43.4%
1Y
n/a
L&C BIOLTD
Market Cap: ₩2.1t
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩81,000.00
7D
6.9%
1Y
250.6%
Qurient
Market Cap: ₩2.1t
A biotech company, engages in the research and development of drugs to address unmet medical needs in Korea and internationally.
A115180
₩49,000.00
7D
84.2%
1Y
592.1%
Oscotec
Market Cap: ₩1.9t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩47,900.00
7D
3.0%
1Y
49.7%
Daewoong Pharmaceutical
Market Cap: ₩1.9t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩168,000.00
7D
7.7%
1Y
39.8%
GC Biopharma
Market Cap: ₩1.7t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩152,400.00
7D
9.9%
1Y
20.8%
G2GBIO
Market Cap: ₩1.7t
A clinical-stage biotech company, provides pharmaceutical products.
A456160
₩106,000.00
7D
26.2%
1Y
n/a
Curiox Biosystems
Market Cap: ₩1.6t
Manufactures and sells automated equipment and consumables for cell analysis processes in South Korea.
A445680
₩90,800.00
7D
1.1%
1Y
545.8%
AbClon
Market Cap: ₩1.4t
Engages in the research and development of antibody drugs in South Korea and Sweden.
A174900
₩73,000.00
7D
38.8%
1Y
479.4%
AprilBioLtd
Market Cap: ₩1.4t
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩61,900.00
7D
11.9%
1Y
272.9%
HK inno.N
Market Cap: ₩1.4t
Engages in the pharmaceutical business in South Korea.
A195940
₩49,350.00
7D
8.3%
1Y
33.9%